KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Non-Current Liabilities (2017 - 2025)

Novartis Ag's Total Non-Current Liabilities history spans 9 years, with the latest figure at $37.1 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 26.15% year-over-year to $37.1 billion; the TTM value through Dec 2025 reached $37.1 billion, up 26.15%, while the annual FY2025 figure was $37.1 billion, 26.15% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $37.1 billion at Novartis Ag, up from $29.4 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $37.1 billion in Q4 2025 and bottomed at $26.8 billion in Q4 2023.
  • The 5-year median for Total Non-Current Liabilities is $29.4 billion (2024), against an average of $31.3 billion.
  • The largest annual shift saw Total Non-Current Liabilities decreased 13.0% in 2022 before it rose 26.15% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $33.8 billion in 2021, then fell by 13.0% to $29.4 billion in 2022, then fell by 8.75% to $26.8 billion in 2023, then rose by 9.79% to $29.4 billion in 2024, then grew by 26.15% to $37.1 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Total Non-Current Liabilities are $37.1 billion (Q4 2025), $29.4 billion (Q4 2024), and $26.8 billion (Q4 2023).